ASTRAZENECA PHARMA INDIA
Back to Income Statement
|
ASTRAZENECA PHARMA INDIA Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,276 Cr | ₹1,716 Cr | ₹1,296 Cr | ₹1,003 Cr | ₹806 Cr |
What is the latest Revenue of ASTRAZENECA PHARMA INDIA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,276 Cr |
| Mar2025 | ₹1,716 Cr |
| Mar2024 | ₹1,296 Cr |
| Mar2023 | ₹1,003 Cr |
| Mar2022 | ₹806 Cr |
How is Revenue of ASTRAZENECA PHARMA INDIA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,276 Cr | 32.59 | |
| Mar2025 | ₹1,716 Cr | 32.48 | |
| Mar2024 | ₹1,296 Cr | 29.17 | |
| Mar2023 | ₹1,003 Cr | 24.50 | |
| Mar2022 | ₹806 Cr | - | |
Compare Revenue of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹20,470.4 Cr | -1.3% | 1% | -11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | -1.3% |
1% |
-11.9% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses